The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug
The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly‘s highly anticipated weight loss drug Zepbound. It is the latest entrant in a field of powerful new obesity medicines including Novo Nordisk’s successful Ozempic and Wegovy, and has been predicted by analysts to become a bestseller. Administered by weekly injection, […]
The post US approves highly anticipated Eli Lilly weight loss drug appeared first on Insider Paper.
https://insiderpaper.com/us-approves-highly-anticipated-eli-lilly-weight-loss-drug/
Comments
0 comment